Skip to search.
 FTSE 100 Up 0.27%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
33.50 Up 1.58(4.95%) 3 Aug 21:00
Add to Portfolio
Prev Close:31.92
Open:32.10
Bid:33.25 x 300
Ask:N/A
1y Target Est:30.38
Beta:0.35
Next Earnings Date: 6-Aug-15SRPT Earnings announcement
Day's Range:32.10 - 34.52
52wk Range:11.33 - 34.66
Volume:1,508,098
Avg Vol (3m):1,646,130
Market Cap:1.39b
P/E (ttm):N/A
EPS (ttm):-4.13
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SRPTUp 4.95%1.39b
ALNYDown 0.95%10.64b
GSKUp 0.16%105.08b
ISISDown 1.77%6.46b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):360.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-4.86
Quarterly EPS Est (Jun-15) :-1.21
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):32.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback